Ventrus Biosciences Revenue, Profits - ASMB Annual Income Statement

Add to My Stocks
$55.22 $2.95 (5.07%) ASMB stock closing price Mar 23, 2018 (Closing)

ASMB stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Ventrus Biosciences stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement for ASMB which shows a YOY revenue decline of 0 is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Ventrus Biosciences assets and Ventrus Biosciences free cash flow, Ventrus Biosciences profits as shown in profit and loss statement give key insights about the business. The net profit for 2016 is $-44.26M and the 2016 revenue is $-.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec20162015201420132012201120102009
Ventrus Biosciences Revenues or Net Sales
Cost Of Goods Sold (COGS)--------
Ventrus Biosciences Gross Profit
Research & Development Expense33.09M18.35M10.71M15.02M19.51M25.27M1.85M2.94M
Selling General & Admin Expense12.18M11.29M13.23M4.57M5.34M8.72M2.91M-
Income Before Depreciation Depletion Amortization-45.27M-29.65M-23.95M-19.6M-24.85M-34M-4.76M-3.34M
Depreciation Depletion Amortization--------
Non Operating Income-1.2M------
Interest Expense------10.53M1.19M
Ventrus Biosciences Pretax Income
Provision for Income Taxes-0.61M-------
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations-44.26M-28.45M-23.78M-19.4M-24.79M-34.34M-15.29M-4.53M
Extraordinary Items & Discontinued Operations--------
Ventrus Biosciences Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS17.23M15.7M7M-----
Average Shares used to compute Basic EPS17.23M15.7M7M-----
Income Before Nonrecurring Items-44.26M-28.45M-23.79M----15.29M-
Income from Nonrecurring Items--------
Ventrus Biosciences Earnings Per Share Basic Net
Ventrus Biosciences Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-2.57-1.81-3.40----123.35-
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Ventrus Biosciences stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2016. Our Ventrus Biosciences revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-44.26M for ASMB stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The ASMB financials along with Ventrus Biosciences historical stock prices provide a lot of details about the firm.

Ventrus Biosciences Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield